Navigation Links
Federal Biomet Hip Lawsuit Litigation Progresses with Recent Case List Update, Scheduling of Upcoming Case Management Conference, Bernstein Liebhard LLP Reports
Date:10/28/2013

(PRWEB) October 28, 2013

A status conference to discuss matters related to federally-filed Biomet hip lawsuit (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) claims is scheduled to take place next month in a federal litigation now housing more than 700 cases, Bernstein Liebhard LLP reports.

A Case Management Order issued in September indicates that an upcoming conference in the federal Biomet hip replacement proceeding established in the U.S. District Court, Northern District of Indiana will be held telephonically on November 18th at 9:00 a.m. This meeting will involve claims over the Biomet M2a Magnum metal-on-metal hip replacement, which has been associated with early failure rates and the need for revision surgery in recipients who have come forward to file Biomet lawsuits. Recent court documents indicate that 725 cases are now pending in this litigation. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

“As we continue to hear from individuals who received the Biomet M2a Magnum hip implant, we are pleased to see progress in the federal Biomet hip lawsuit litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Right now, the Firm is offering free and confidential case reviews to individuals who received this metal-on-metal hip implant and may now be experiencing complications.

Biomet Hip Lawsuits
According to a recent Case List update from the U.S. Judicial Panel on Multidistrict Litigation (JPML) a total of 725 Biomet hip lawsuits were pending in the Northern District of Indiana as of October 17th, 2013. These cases similarly allege that Biomet Inc. failed to properly warn patients and their doctors about the potential for early failure complications to stem from use of its product. Given the design of this implant, which consists of a chromium-cobalt femoral head and acetabular shell, dangerous amounts of metal debris may shed into the blood stream.

Metal hip replacement implants like the Biomet M2a Magnum have increasingly become a subject of concern by the U.S. Food and Drug Administration (FDA). In January 2013, the federal agency proposed new regulations regarding metal-on-metal hip devices that would require all devices to undergo rigorous testing prior to receiving market approval. In its alert, the FDA advised all metal hip recipients to undergo blood testing if they are experiencing symptoms that may indicate premature device failure.

Individuals who may have experienced injuries stemming from the Biomet M2a Magnum hip implant may be eligible to receive compensation for the out-of-pocket medical expenses, lost wages and other damages they sustained. Learn more about the potential side effects that may result from use of this device by visiting Bernstein Liebhard LLP’s website. For a free case review, contact one of our Firm’s attorneys at 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/biomet-hip-lawsuit/biomet-hip-replacement/prweb11275827.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Federal Biomet Hip Lawsuit Litigation Progresses with Recent Case List Update, Scheduling of Upcoming Case Management Conference, Bernstein Liebhard LLP Reports
2. Mirena IUD Lawsuit Help Update: Resource4thePeople Comments on New Developments in State and Federal Court Litigation
3. U.S. Federal Panel Vacates Order to Transfer Mirena Lawsuit to New York Litigation, Bernstein Liebhard LLP Reports
4. New Transvaginal Mesh Lawsuits Assistance: Resource4thePeople Reports Key Trials Scheduled by Federal Judge
5. Status Conference Scheduled for December in Federal Ethicon Transvaginal Mesh Lawsuit Litigation, More than 10,270 Gynecare Cases Now Filed in Proceeding
6. Over 2,500 Cases Now Filed in Federal Actos Lawsuit Litigation; Case Management Conference Scheduled to Take Place on Thursday
7. PCMA: Eight Ways to Reduce Federal Health Spending and Improve Prescription Drug Benefits in Medicare and Medicaid
8. Wright Hip Lawsuit News: Federal Judge Allows Certain Claims to Proceed in Wright Profemur Hip Replacement Lawsuit, Bernstein Liebhard LLP Reports
9. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Judge’s Decision to Uphold Verdict in First Federal Trial of C.R. Bard Vaginal Mesh Lawsuit
10. Pharmaceutical Insiders with Proof of Company’s Improper Relationships: Federal Law Offers Whistleblowers Opportunity for Sizable Financial Compensation, Parker Waichman LLP Says
11. Stryker Hip Lawsuit News: Key Milestone Achieved in Federal Court Cases, Rottenstein Law Group LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
Breaking Medicine Technology: